ASF-006 sodium
ASF-006 sodium, a tetrapodal tryptophan derivative, is a potent viral invasion inhibitor. ASF-006 sodium shows potent antiviral activity against different SARS-CoV-2 Omicron variants but not against the ancestral SARS-CoV.2 strain (Wuhan-Hu-1). ASF-006 sodium competitively inhibits receptor-binding domain (RBD)-ACE2 binding via an allosteric mechanism. ASF-006 sodium inhibits Omicron BA.1, Omicron XBB.1.5, respiratory syncytial virus (RSV) and Ebola virus infection with IC50s of 0.02 μM, 0.3 μM, 1.52 μM and 0.2 μM, respectively. ASF-006 sodium inhibits cell entry of both HIV and enterovirus A71[1].
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Formel: C125H80N8Na20O48
- Molecular Weight:2921.79
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
In Vitro
ASF-006 sodium (20 μM) shows strong inhibition of infection by VSV pseudotyped, displaying Omicron BA.2 or BA.4/5 subvariants on its surface in the absence of significant toxicity to cells[1].
ASF-006 sodium against different SARS-CoV-2 Omicron variants but also highlight its limited activity against more ancestral strains (Wuhan-Hu-1) or distant coronaviruses (SARS-CoV)[1].
ASF-006 sodium shows strong antiviral activity against RSV-A, with IC50 values ranging between 0.05 and 0.2 μM when infecting A549, HEp-2, or Vero cells[1].
ASF-006 sodium shows no antiviral activity against VSV (Rhabdoviridae), Nipah virus, or Sindbis virus[1].
ASF-006 sodium interacts with the S protein, interfering with binding to its cellular receptor ACE2[1].
ASF-006 sodium binds to RBDBA.1 and SBA.1 proteins with Kd values of ∼60 μM and 5 μM, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:K18-hACE2 (genetically modified to express human ACE2 under the control of the human cytokeratin 18 promoter; 6-week-old) were infected with SARS-CoV-2 Omicron BA.1[1]
-
Dosage:100 mg/kg (50 μL)
-
Administration:Intranasal; once daily; 3 days
-
Result:A significant >3.5-fold reduction in viral load was observed in the lungs of treated mice compared to the vehicle group, as determined by quantitative RT-PCR.
No signs of drug toxicity were observed.
Chemical Information
-
Molecular Weight 2921.79
-
Formel C125H80N8Na20O48
-
SMILES
O=C(C(CC1=C(C2=CC(C(O[Na])=O)=CC(C(O[Na])=O)=C2)NC3=C1C=CC=C3C4=CC(C(O[Na])=O)=CC(C(O[Na])=O)=C4)NC(CCOCC(COCCC(NC(C(O[Na])=O)CC(C5=C(N6)C(C7=CC(C(O[Na])=O)=CC(C(O[Na])=O)=C7)=CC=C5)=C6C8=CC(C(O[Na])=O)=CC(C(O[Na])=O)=C8)=O)(COCCC(NC(CC9=C(C%10=CC(C(O[Na])=O)=CC(C(O[Na])=O)=C%10)NC%11=C9C=CC=C%11C%12=CC(C(O[Na])=O)=CC(C(O[Na])=O)=C%12)C(O[Na])=O)=O)COCCC(NC(CC%13=C(C%14=CC(C(O[Na])=O)=CC(C(O[Na])=O)=C%14)NC%15=C%13C=CC=C%15C%16=CC(C(O[Na])=O)=CC(C(O[Na])=O)=C%16)C(O[Na])=O)=O)=O)O[Na]
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Cell invasion
Cell invasion is the ability of cells to migrate from one area to another via the extracellular matrix. Cell invasion is the response of normal and cancer cells to chemical and mechanical stimuli. Before migrating to a new region, the extracellular matrix is degraded by proteases within the cell. Cell invasion often occurs during wound repair, vascularization and inflammation, abnormal tissue invasion, and tumor cell metastasis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)